Tower Research Capital LLC (Trc) Cara Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 11,425 shares of CARA stock, worth $3,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,425

Previous 14,996 23.81%

Holding current value

$3,770

Previous $11,000 9.09%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.52 - $1.05 $1,856 - $3,749	-3,571 Reduced 23.81%	11,425 $10,000
Q4 2023 Feb 13, 2024	BUY	$0.6 - $1.65 $4,032 - $11,089	6,721 Added 81.22%	14,996 $11,000
Q3 2023 Nov 14, 2023	SELL	$1.67 - $3.33 $1,327 - $2,647	-795 Reduced 8.77%	8,275 $13,000
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $13,855 - $24,186	4,896 Added 117.3%	9,070 $25,000
Q1 2023 May 09, 2023	SELL	$4.89 - $12.27 $66,225 - $166,172	-13,543 Reduced 76.44%	4,174 $20,000

Q4 2022 Feb 10, 2023	BUY	$8.88 - $12.77 $47,623 - $68,485	5,363 Added 43.41%	17,717 $191,000
Q3 2022 Nov 10, 2022	BUY	$8.24 - $12.56 $45,921 - $69,996	5,573 Added 82.19%	12,354 $116,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $5,490 - $10,200	737 Added 12.19%	6,781 $62,000
Q1 2022 May 12, 2022	SELL	$9.94 - $12.65 $15,735 - $20,024	-1,583 Reduced 20.76%	6,044 $73,000
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $123,233 - $186,442	-10,278 Reduced 57.4%	7,627 $93,000
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $172,256 - $239,518	14,914 Added 498.63%	17,905 $277,000
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $11,538 - $27,205	-932 Reduced 23.76%	2,991 $43,000
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $572 - $824	38 Added 0.98%	3,923 $85,000
Q4 2020 Feb 16, 2021	SELL	$12.72 - $16.16 $259,055 - $329,114	-20,366 Reduced 83.98%	3,885 $59,000
Q3 2020 Nov 16, 2020	BUY	$12.34 - $17.92 $222,613 - $323,276	18,040 Added 290.45%	24,251 $308,000
Q2 2020 Aug 13, 2020	BUY	$12.39 - $17.33 $76,954 - $107,636	6,211 New	6,211 $106,000
Q1 2020 May 15, 2020	SELL	$9.12 - $17.78 $59,106 - $115,232	-6,481 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$16.11 - $25.98 $102,797 - $165,778	6,381 Added 6381.0%	6,481 $104,000
Q3 2019 Nov 05, 2019	BUY	$18.28 - $26.91 $1,828 - $2,691	100 New	100 $2,000
Q2 2019 Aug 13, 2019	SELL	$17.68 - $21.57 $7,195 - $8,778	-407 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$14.41 - $19.64 $5,864 - $7,993	407 New	407 $8,000
Q3 2018 Nov 13, 2018	SELL	$17.57 - $23.95 $808 - $1,101	-46 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$11.6 - $19.27 $545 - $905	-47 Reduced 50.54%	46 $1,000
Q1 2018 May 15, 2018	BUY	$11.77 - $16.08 $1,094 - $1,495	93 New	93 $1,000

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $17.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Cara Therapeutics, Inc. Transaction History